3 - [2- (3-amino-2-oxo-2H-pyridin-1-YL) - acetylamino] - 4oxo-pentanoic acid derivatives and their use as caspase inhibitors

Details for Australian Patent Application No. 2004243308 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Mortimore, Michael; Charrier, JeanDamien; Knegtel, Ronald; Studley, John R.; Durrant, Steven; Brenchley, Guy

Agent Cullens

Pub. Number AU-B-2004243308

PCT Pub. Number WO2004/106304

Priority 60/473,622 27.05.03 US

Filing date 27 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 29 September 2011

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/106304 Priority application(s): WO2004/106304

29 September 2011 Application Accepted

  Published as AU-B-2004243308

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243314-Organic recycling with metal addition

2004243304-Crystalline form of beta2 adrenergic receptor agonist